Diederik van Bodegom

Author

Dana-Farber Cancer Institute

Also Known As

D van Bodegom, D. van Bodegom, Diederik Van Bodegom, Diederik van Bodegom, Diederik van Bodegom

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Harvard University Press Broad Institute Brigham and Women's Hospital

About

Diederik van Bodegom is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	320
2	Cell Biology	4	4	320
3	Cell Signaling	3	3	183
4	Pathology	2	2	63
5	Immunology	1	1	120

Diederik van Bodegom

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane, Blood	2013	423
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition Oliver Weigert, Andrew A. Lane, Liat Bird, The Journal of Experimental Medicine	2012	161
p53 regulates a non-apoptotic death induced by ROS Joan Montero, Chaitali Dutta, Diederik van Bodegom, Cell Death and Differentiation Non-apoptotic DeathApoptosisCell DeathTumor SuppressorMedicine	2013	137
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation Andrew A. Lane, Bjoern Chapuy, Charles Y. Lin, Nature Genetics	2014	131
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp, Cancer Cell Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematology	2015	120
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling Jun Zhong, Jyoti Sharma, Rajesh Raju, Database	2014	99
BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death Chaitali Dutta, Tovah A. Day, Nadja Kopp, Cancer Research	2012	54
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2 Diederik van Bodegom, Jun Zhong, Nadja Kopp, Blood	2012	46
The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression Diederik van Bodegom, Zubaida Saifudeen, Susana Dipp, Journal of Biological Chemistry Transcriptional RegulationCell RegulationPathologyP53-mediated Transcriptional RepressionTumor Suppressor	2006	46
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma Caron A. Jacobson, Nadja Kopp, Jacob V. Layer, Blood	2016	42

Page 1